Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Defraia, E."'
Autor:
Colombino M., Paliogiannis P., Cossu A., Santeufemia D.A., Pazzola A., Fadda G.M., Pirina P., Fois A., Putzu C., Ginesu G., Porcu A., Astara G., Scartozzi M., Carta A.M., Defraia E., Guerzoni D., Porcu G., Bardino G., Sini C., Capelli F., Sarobba M.G., Sini M.C., Casula M., Palomba G., Manca A., Pisano M., Doneddu V., Palmieri G.
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-10 (2019)
BMC pulmonary medicine (Online) 19 (2019). doi:10.1186/s12890-019-0964-x
info:cnr-pdr/source/autori:Colombino M.; Paliogiannis P.; Cossu A.; Santeufemia D.A.; Pazzola A.; Fadda G.M.; Pirina P.; Fois A.; Putzu C.; Ginesu G.; Porcu A.; Astara G.; Scartozzi M.; Carta A.M.; Defraia E.; Guerzoni D.; Porcu G.; Bardino G.; Sini C.; Capelli F.; Sarobba M.G.; Sini M.C.; Casula M.; Palomba G.; Manca A.; Pisano M.; Doneddu V.; Palmieri G./titolo:EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma/doi:10.1186%2Fs12890-019-0964-x/rivista:BMC pulmonary medicine (Online)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:19
BMC Pulmonary Medicine
BMC pulmonary medicine (Online) 19 (2019). doi:10.1186/s12890-019-0964-x
info:cnr-pdr/source/autori:Colombino M.; Paliogiannis P.; Cossu A.; Santeufemia D.A.; Pazzola A.; Fadda G.M.; Pirina P.; Fois A.; Putzu C.; Ginesu G.; Porcu A.; Astara G.; Scartozzi M.; Carta A.M.; Defraia E.; Guerzoni D.; Porcu G.; Bardino G.; Sini C.; Capelli F.; Sarobba M.G.; Sini M.C.; Casula M.; Palomba G.; Manca A.; Pisano M.; Doneddu V.; Palmieri G./titolo:EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma/doi:10.1186%2Fs12890-019-0964-x/rivista:BMC pulmonary medicine (Online)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:19
BMC Pulmonary Medicine
Background Lung cancer is one of the most incident neoplastic diseases, and a leading cause of death for cancer worldwide. Knowledge of the incidence of druggable genetic alterations, their correlation with clinical and pathological features of the d
Publikováno v:
In Annals of Oncology October 2017 28 Supplement 6:vi15-vi15
Autor:
De Giorgi, U, Carteni, G, Giannarelli, D, Basso, U, Galli, L, Cortesi, E, Caserta, C, Pignata, S, Sabbatini, R, Bearz, A, Buti, S, Lo Re, G, Berruti, A, Bracarda, S, Cognetti, F, Rastelli, F, Fornarini, G, Porta, C, Turci, D, Sternberg, Cn, Procopio, G, Falcone, A, Roila, F, Cascinu, S, Tirelli, U, Giustini, L, Sobrero, A, Cappuzzo, F, Tortora, G, Tassinari, D, Passalacqua, R, Pazzola, A, Surico, G, Maio, M, Benedetti, G, Barone, C, Adamo, V, Ricevuto, E, De Censi, A, Spada, M, Tonini, G, Pinto, C, Ciuffreda, L, Ruggeri, Em, Bengala, C, Scotti, V, Fagnani, D, Bonetti, A, Mitterer, M, Castiglione, F, Bidoli, P, Ferrau, F, Crino, L, Frassoldati, A, Marchetti, P, Mini, E, Scoppola, A, Verusio, C, Favaretto, A, Di Costanzo, F, Fasola, G, Merlano, M, Artioli, F, Di Leo, A, Romito, S, Maestri, A, Giorgio, Cg, Ionta, Mt, Verderame, F, Zampa, G, Numico, G, Minelli, M, Tagliaferri, P, Foa, P, Palmiotti, G, De Placido, S, Mattioli, R, Iuliano, F, Defraia, E, Siena, S, Clerico, M, Salvagno, L, Ceresoli, Gl, Bernardo, A, Di Lieto, M, Moroni, M, Maisano, M, Scartozzi, M, Scagliotti, G, Soraru, M, Pepe, S, Scaltriti, A, Gebbia, V, Testa, E, Lorusso, V, Bordonaro, R, De Signoribus, G, Tedde, N, Santoro, A, Francini, G, Aondio, G
Objective: To report the safety and efficacy results of patients enrolled in the Italian Nivolumab Renal Cell Cancer Expanded Access Programme. Patients and Methods: Patients with metastatic renal cell cancer (mRCC) previously treated with agents tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc1bee2a040cf0f99f4bf3071f70212
http://hdl.handle.net/2318/1693656
http://hdl.handle.net/2318/1693656
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
De Marinis, Filippo, Ardizzoni, Andrea, Fontanini, Gabriella, Grossi, Francesco, Cappuzzo, Federico, Novello, Silvia, Santo, Antonio, Lorusso, Vito, Cortinovis, Diego, Iurlaro, Monica, Galetta, Domenico, Gridelli, Cesare, Pedrazzoli P, Siena S, Alabiso O, Bilancia D, Cinieri S, Cartenì G, Fasola G, Ferraù F, Milella M, Contu A, Giuffrida D, Illiano A, Ravaioli A, Zaniboni A, Bettini A, Caprioli A, Longo F, Cruciani G, Defraia E, Favaretto A, Amadori D, Clerico M, Di Costanzo F, Gamucci T, Caruso M, Iacobelli S, Pinotti G, Pozzessere D, Maiello E, Marchetti P, Passalacqua R, Pavesi L, Tortora G, Aglietta M, Brandes A, Ciuffreda L, Daniele B, Demichelis C, Romito S, Tamberi S, Barni S, Barbieri F, Giordano M, Bracarda S, Crinò L, Marzano N, Merlano M, Numico G., BIANCO, ROBERTO
Publikováno v:
Clinical lung cancer. 15(5)
Introduction/Background Patients with advanced NSCLC who experience disease progression after second-line therapy might receive further active treatment. LIFE was an Italian cohort multicenter observational study composed of a cross-sectional and a l
Autor:
Colombino M, Palomba G, Defraia E, Porcu G, Pazzola A, Cordero L, Fadda G M, Ortu S, Mura S, Baldinu Paola, M R, Carta A, Sotgiu M I, Guerzoni D, Saba E M, Scotto T, Contu A, Tanda F, Palmieri G, Cossu A on behalf of the Sardinian Translational Oncology Group (STOG).
Publikováno v:
Tumori. Supplemento 13 (2012).
info:cnr-pdr/source/autori:Colombino M, Palomba G, Defraia E, Porcu G, Pazzola A, Cordero L, Fadda G M, Ortu S, Mura S, Baldinu Paola, M R, Carta A, Sotgiu M I, Guerzoni D, Saba E M, Scotto T, Contu A, Tanda F, Palmieri G, Cossu A on behalf of the Sardinian Translational Oncology Group (STOG)./titolo:Prevalence of EGFR, KRAS and BRAF mutations among patients with non-small-cell lung cancer from Sardinia/doi:/rivista:Tumori. Supplemento/anno:2012/pagina_da:/pagina_a:/intervallo_pagine:/volume:13
info:cnr-pdr/source/autori:Colombino M, Palomba G, Defraia E, Porcu G, Pazzola A, Cordero L, Fadda G M, Ortu S, Mura S, Baldinu Paola, M R, Carta A, Sotgiu M I, Guerzoni D, Saba E M, Scotto T, Contu A, Tanda F, Palmieri G, Cossu A on behalf of the Sardinian Translational Oncology Group (STOG)./titolo:Prevalence of EGFR, KRAS and BRAF mutations among patients with non-small-cell lung cancer from Sardinia/doi:/rivista:Tumori. Supplemento/anno:2012/pagina_da:/pagina_a:/intervallo_pagine:/volume:13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::da313686cbbb79c86ebd947dfd1ad44b
http://www.cnr.it/prodotto/i/216242
http://www.cnr.it/prodotto/i/216242
Autor:
Cau, M.C., Puxeddu, R., Tore, G., Pirri, S., Pusceddu, Z., Aste, C., Carta, F., Summo, O., Tandurella, I., Carta, P., Aste, M.G., Defraia, E., Gutman, G., Mascia, L., Mascia, M.G., Ghiani, M.
Publikováno v:
In Annals of Oncology October 2017 28 Supplement 6:vi74-vi74
Autor:
Sini, C., Carta, A.M., Bardino, G., Saba, E.M., Coinu, A., Defraia, E., Ortu, S., Schintu, M.G., Pira, T., Frau, B., Soru, G., Masale, A.
Publikováno v:
In Annals of Oncology October 2017 28 Supplement 6:vi63-vi63
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.